EHS
EHS

New patent for Catalyst Pharms drug FIRDAPSE – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Catalyst Pharms drug FIRDAPSE


Annual Drug Patent Expirations for FIRDAPSE

Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

This drug has two patent family members in two countries.

The generic ingredient in FIRDAPSE is amifampridine phosphate. One supplier is listed for this compound. Additional details are available on the amifampridine phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Catalyst Pharms drug FIRDAPSE



Source link

EHS
Back to top button